Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000

Abstract

A deficit in colorectal cancer survival in Denmark and in the UK compared to Sweden, Norway and Finland was found in the EUROCARE studies. We set out to explore if these differences still exist. Patients diagnosed with colorectal cancer as their first invasive cancer at age 15-89 in the period 1994-2000 were identified using data from 11 cancer registries in the UK and from four Nordic countries. Five-year relative period survival using deaths in 1999-2000 following cancers diagnosed in 1994-2000 was analysed with excess mortality risk modelling. Follow-up time since diagnosis with age as an effect-modifier in the first half year was the most important factor with the highest excess risk of death immediately after diagnosis and with higher age and decreasing with length of follow-up. Variations between countries were bigger in the first half year following diagnosis than in the interval 0.5-5 years with about 30% higher risk in UK and Denmark. The differences between countries are still substantial and the order has not changed, even if the five year relative survival has improved since the EUROCARE studies. Patient management, diagnostics, and comorbidity likely explain the excess deaths in UK and Denmark during the first 6 months. The effect of stage and quality of management and treatment should be examined in population based studies with detailed patient information. Use of more detailed age-intervals than conventionally applied in survival studies proved to be important in statistical modelling and is recommended for future studies. ' 2007 Wiley-Liss, Inc.

Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level

“…15,16 According to standard practice in population-based cancer survival analysis, relative rather than absolute survival was calculated. Relative survival reflects survival of cancer patients compared to survival of the general population.…”

Thirty-day postoperative mortality after colorectal cancer surgery in England

“…International variation in survival is greatest in this period,3 suggesting that differences in the quality of care may explain some of the variation. A growing body of evidence also indicates variation in the type and quality of treatment delivered at a national level 5 6.…”

A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004

“…If variations in the extent of disease at diagnosis or initial treatment account for the observed variations in survival, however, then differences at earlier time points in the course of the disease may be more revealing. For example, recent studies have demonstrated that the greatest differences in survival between the Nordic countries and the UK occurred in the first 6 months after diagnosis 7 8. These differences were also strongly age dependent, with excess mortality and the differences between countries increasing substantially with age.…”

“…A number of previous studies have presented differences between countries as either cumulative relative survival (usually at 5 years) or relative risk (RR) of increased mortality 7. This can be misleading when the underlying risk is low as even a moderately large RR may have little impact on the number of deaths.…”